In the presence of an AVM, the first question to consider is if the AVM requires treatment. Many factors must be taken into consideration including:
• Symtomatology
• The AVM’s characteristics (location, size, draining pattern, associated angiographic features)
• The patient’s characteristics (age, comorbidities)
If the AVM presents acutely with a hemorrhage, the patient’s clinical condition may require urgent surgery to evacuate the blood clot and relieve increased intracranial pressure. An external drain positioned in the ventricles may be required to monitor intracranial pressure and drain cerebrospinal fluid. The AVM is rarely addressed in such acute circumstances.
If the AVM presents with de novo seizure, standard anticonvulsant medication is generally sufficient in the acute setting to obtain seizure control.
When a decision to treat an AVM is taken, three modalities may be considered:
• Surgery Resection
• Endovascular Treatment (embolization)
• Radiosurgery
• A combination of any of the treatment modalities
Surgery is the treatment of choice for easily accessible AVMs of smaller size. Through a craniotomy, the AVM is approached is a systematic fashion, coagulating the feeding arteries and at last obliterating the draining vein. The vascular conglomerate is completely removed, definitively curing the patient.
Endovascular embolization implies blocking the high-velocity shunt of blood from the arteries into the dilated veins. Numerous thrombosing agents may be used. Although embolization has succeeded in completely obliterating AVMs, it is most often used to reduce AVM and treat angiographic features potentially associated with a higher risk of bleeding.
Radiosurgery is an option to treat AVMs located in eloquent regions, measuring 3cm in diameter or less and presenting deep venous drainage. High radiation doses delivered to the AVM induce thrombosis of the abnormal vessels. Importantly, not all patients achieve thrombosis of the AVM following radiosurgery and those that do achieve thrombosis 1-4 years after treatment. During this interval, the patient remains at risk for hemorrhage from the AVM.
Angiographic follow-up is requested, regardless of the treatment modality, as AVMs have been described to recur after complete exclusion.